3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
7
Unknown
2
Terminated
1
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Malnutrition
3
Weight Loss
2
Neoplasms
2
Lung Neoplasms
2
Breast Neoplasms
2
Risk Reduction Behavior
1
Rectal Neoplasms
1
Protein Deficiency
1
Nutrition Related Cancer
1
Inflammation
1
Hematologic Neoplasms
1
Gestational Weight Gain
1
Gastrointestinal Neoplasms
1
Fasting
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Cachexia
1
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Nutrition Assessment
×
Clear all
NCT05364359
2022-05-06
HCP
University of Copenhagen
Phase NA
Unknown
40 enrolled
NCT03390816
2019-04-04
NutriAgeCancer
Société Francophone d'Onco-Gériatrie
Unknown
1,886 enrolled